Tandem Diabetes Care Company Profile (NASDAQ:TNDM)

About Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care logoTandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump's cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: N/A
  • Symbol: NASDAQ:TNDM
  • CUSIP: N/A
  • Web: www.tandemdiabetes.com
Capitalization:
  • Market Cap: $127.08 million
  • Outstanding Shares: 50,228,000
Average Prices:
  • 50 Day Moving Avg: $5.92
  • 200 Day Moving Avg: $7.52
  • 52 Week Range: $2.27 - $70.00
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.31
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $81.51 million
  • Price / Sales: 1.56
  • Book Value: ($0.36) per share
  • Price / Book: -7.03
Profitability:
  • EBITDA: ($76,170,000.00)
  • Net Margins: -110.70%
  • Return on Equity: -1,177.11%
  • Return on Assets: -87.18%
Debt:
  • Debt-to-Equity Ratio: -4.09%
  • Current Ratio: 2.11%
  • Quick Ratio: 1.28%
Misc:
  • Average Volume: 1.49 million shs.
  • Beta: 0.33
  • Short Ratio: 3.34
 

Frequently Asked Questions for Tandem Diabetes Care (NASDAQ:TNDM)

What is Tandem Diabetes Care's stock symbol?

Tandem Diabetes Care trades on the NASDAQ under the ticker symbol "TNDM."

When did Tandem Diabetes Care's stock split? How did Tandem Diabetes Care's stock split work?

Shares of Tandem Diabetes Care reverse split on the morning of Tuesday, October 10th 2017. The 1-10 reverse split was announced on Monday, October 9th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 9th 2017. An investor that had 100 shares of Tandem Diabetes Care stock prior to the reverse split would have 10 shares after the split.

How were Tandem Diabetes Care's earnings last quarter?

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) issued its earnings results on Thursday, July, 27th. The company reported ($4.40) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($4.80) by $0.40. The firm earned $21.30 million during the quarter, compared to analysts' expectations of $21.74 million. Tandem Diabetes Care had a negative return on equity of 1,177.11% and a negative net margin of 110.70%. The business's revenue was down 7.4% compared to the same quarter last year. During the same period in the previous year, the firm earned ($6.00) earnings per share. View Tandem Diabetes Care's Earnings History.

When will Tandem Diabetes Care make its next earnings announcement?

Tandem Diabetes Care is scheduled to release their next quarterly earnings announcement on Thursday, October, 26th 2017. View Earnings Estimates for Tandem Diabetes Care.

Where is Tandem Diabetes Care's stock going? Where will Tandem Diabetes Care's stock price be in 2017?

9 brokers have issued twelve-month target prices for Tandem Diabetes Care's shares. Their predictions range from $15.00 to $90.00. On average, they expect Tandem Diabetes Care's stock price to reach $32.43 in the next year. View Analyst Ratings for Tandem Diabetes Care.

Who are some of Tandem Diabetes Care's key competitors?

Who are Tandem Diabetes Care's key executives?

Tandem Diabetes Care's management team includes the folowing people:

  • Dick P. Allen, Chairman of the Board
  • Kim D. Blickenstaff, President, Chief Executive Officer, Board Member
  • John Cajigas, Chief Financial Officer, Treasurer
  • John F. Sheridan, Chief Operating Officer, Executive Vice President
  • Brian Hansen, Chief Commercial Officer, Executive Vice President
  • Susan M. Morrison, Chief Administrative Officer
  • Lori Gildea, Vice President - Sales
  • David B. Berger Esq., General Counsel, Corporate Secretary
  • Edward L. Cahill, Independent Director
  • Fred E. Cohen Ph.D. M.D., Independent Director

How do I buy Tandem Diabetes Care stock?

Shares of Tandem Diabetes Care can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tandem Diabetes Care's stock price today?

One share of Tandem Diabetes Care stock can currently be purchased for approximately $2.53.


MarketBeat Community Rating for Tandem Diabetes Care (NASDAQ TNDM)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  146 (Vote Outperform)
Underperform Votes:  166 (Vote Underperform)
Total Votes:  312
MarketBeat's community ratings are surveys of what our community members think about Tandem Diabetes Care and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Tandem Diabetes Care (NASDAQ:TNDM) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 5 Hold Ratings, 4 Buy Ratings
Consensus Rating:Hold (Score: 2.44)
Consensus Price Target: $32.43 (1,181.76% upside)
Consensus Price Target History for Tandem Diabetes Care (NASDAQ:TNDM)
Price Target History for Tandem Diabetes Care (NASDAQ:TNDM)
Analysts' Ratings History for Tandem Diabetes Care (NASDAQ:TNDM)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/10/2017WedbushReiterated RatingOutperform$50.00 -> $17.00N/AView Rating Details
10/6/2017Piper Jaffray CompaniesReiterated RatingHold$15.00N/AView Rating Details
5/3/2017B. RileyReiterated RatingNeutral$15.00MediumView Rating Details
4/10/2017Cowen and CompanyDowngradeOutperform -> Market Perform$15.00MediumView Rating Details
3/9/2017Northcoast ResearchReiterated RatingBuyN/AView Rating Details
11/2/2016Deutsche Bank AGLower Price TargetBuy$140.00 -> $90.00N/AView Rating Details
11/2/2016Feltl & Co.DowngradeStrong-Buy -> BuyN/AView Rating Details
11/2/2016Robert W. BairdDowngradeOutperform -> Neutral$110.00 -> $40.00N/AView Rating Details
11/2/2016Stifel NicolausDowngradeBuy -> Hold$150.00 -> $35.00N/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingNeutralN/AView Rating Details
3/24/2016Bank of America CorporationDowngradeNeutral -> UnderperformN/AView Rating Details
10/21/2015William BlairReiterated RatingMarket PerformN/AView Rating Details
(Data available from 10/21/2015 forward)

Earnings

Earnings History for Tandem Diabetes Care (NASDAQ:TNDM)
Earnings by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)
Earnings History by Quarter for Tandem Diabetes Care (NASDAQ TNDM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/30/2017($0.44)N/AView Earnings Details
7/27/2017Q2 2017($4.80)($4.40)$21.74 million$21.30 millionViewN/AView Earnings Details
4/27/2017Q1 2017($6.60)($7.50)$15.72 million$17.50 millionViewN/AView Earnings Details
3/8/2017Q4 2016($6.50)($4.80)$22.75 million$24.80 millionViewListenView Earnings Details
7/28/2016Q216($6.50)($6.00)$23.08 million$23.00 millionViewListenView Earnings Details
4/28/2016Q116($6.90)($6.80)$17.67 million$20.06 millionViewN/AView Earnings Details
2/24/2016Q415($5.10)($4.00)$29.17 million$29.10 millionViewListenView Earnings Details
10/29/2015Q3($8.00)($6.50)$12.58 million$15.70 millionViewListenView Earnings Details
7/30/2015Q215($7.10)($6.50)$14.92 million$15.70 millionViewListenView Earnings Details
4/30/2015Q115($7.90)($8.30)$12.19 million$12.30 millionViewN/AView Earnings Details
2/24/2015Q414($8.10)($7.80)$17.16 million$17.90 millionViewN/AView Earnings Details
11/6/2014Q314($8.20)($8.50)$13.60 million$13.50 millionViewN/AView Earnings Details
7/31/2014Q214($9.10)($8.30)$10.36 million$10.26 millionViewN/AView Earnings Details
5/6/2014Q1($6.90)($9.60)$8.24 million$8.10 millionViewN/AView Earnings Details
11/8/2011$2.50$1.80ViewN/AView Earnings Details
8/9/2011$2.60$2.00ViewN/AView Earnings Details
5/10/2011$2.40$2.40ViewN/AView Earnings Details
3/14/2011$2.90$1.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Tandem Diabetes Care (NASDAQ:TNDM)
2017 EPS Consensus Estimate: ($3.17)
2018 EPS Consensus Estimate: ($1.17)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175($0.81)($0.62)($0.71)
Q2 20174($0.63)($0.37)($0.46)
Q3 20174($3.82)($0.33)($1.25)
Q4 20175($2.81)($0.21)($0.76)
Q1 20182($0.34)($0.34)($0.34)
Q2 20182($0.34)($0.28)($0.31)
Q3 20182($0.28)($0.28)($0.28)
Q4 20182($0.28)($0.20)($0.24)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Tandem Diabetes Care (NASDAQ:TNDM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Tandem Diabetes Care (NASDAQ:TNDM)
Insider Ownership Percentage: 20.90%
Insider Trades by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)
Institutional Ownership by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)
Insider Trades by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/13/2017Kim D BlickenstaffCEOBuy285,700$3.50$999,950.00View SEC Filing  
3/23/2017Kim D BlickenstaffCEOBuy1,600,000$1.25$2,000,000.00View SEC Filing  
8/1/2016John F SheridanEVPSell15,000$6.52$97,800.00View SEC Filing  
5/2/2016John F SheridanCOOSell2,000$10.61$21,220.00View SEC Filing  
4/22/2016John F SheridanCOOSell2,000$10.00$20,000.00View SEC Filing  
3/7/2016John F SheridanCOOSell4,000$10.01$40,040.00View SEC Filing  
2/26/2016Dick AllenDirectorBuy10,000$8.24$82,400.00View SEC Filing  
12/1/2015John F. SheridanCOOSell2,000$10.14$20,280.00View SEC Filing  
11/2/2015John F. SheridanCOOSell4,000$10.00$40,000.00View SEC Filing  
9/14/2015John F. SheridanCOOSell2,000$12.51$25,020.00View SEC Filing  
5/1/2015John F SheridanCOOSell2,000$13.72$27,440.00View SEC Filing  
4/1/2015John F SheridanCOOSell2,000$12.47$24,940.00View SEC Filing  
2/2/2015John F SheridanCOOSell2,000$12.06$24,120.00View SEC Filing  
1/2/2015John F SheridanCOOSell2,000$12.75$25,500.00View SEC Filing  
12/12/2014Dick AllenDirectorBuy10,000$11.95$119,500.00View SEC Filing  
12/1/2014John F SheridanCOOSell2,000$13.55$27,100.00View SEC Filing  
11/3/2014John F SheridanCOOSell2,000$16.00$32,000.00View SEC Filing  
10/1/2014John F SheridanCOOSell2,000$13.07$26,140.00View SEC Filing  
9/2/2014John F SheridanCOOSell2,000$13.99$27,980.00View SEC Filing  
8/1/2014John F SheridanCOOSell2,000$15.04$30,080.00View SEC Filing  
7/1/2014John F SheridanCOOSell2,000$16.42$32,840.00View SEC Filing  
6/18/2014John F SheridanCOOSell2,000$16.75$33,500.00View SEC Filing  
11/13/2013David B BergerGeneral CounselBuy2,000$15.00$30,000.00View SEC Filing  
11/13/2013Hlm Venture Partners Ii, L.P.Major ShareholderBuy200,000$15.00$3,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Tandem Diabetes Care (NASDAQ:TNDM)
Latest Headlines for Tandem Diabetes Care (NASDAQ:TNDM)
Source:
DateHeadline
nasdaq.com logoWednesday 10/18 Insider Buying Report: TNDM, ODC - Nasdaq
www.nasdaq.com - October 19 at 9:51 AM
americanbankingnews.com logoTandem Diabetes Care, Inc. (TNDM) CEO Purchases $999,950.00 in Stock
www.americanbankingnews.com - October 17 at 7:26 PM
finance.yahoo.com logoTandem Diabetes Care Schedules Third Quarter 2017 Earnings Press Release and Conference Call
finance.yahoo.com - October 17 at 8:12 AM
streetinsider.com logoTandem Diabetes (TNDM) Prices 4.63M Share Common Offering at $3.50/Sh
www.streetinsider.com - October 15 at 7:38 AM
seekingalpha.com logoTandem Diabetes Care prices equity offering; shares down 31% premarket
seekingalpha.com - October 15 at 7:38 AM
benzinga.com logo7 Stocks To Watch For October 13, 2017 - Benzinga
www.benzinga.com - October 14 at 8:39 AM
nasdaq.com logoHealth Care Sector Update for 10/13/2017: TNDM,PZRX,ATRS - Nasdaq
www.nasdaq.com - October 14 at 8:39 AM
benzinga.com logoMid-Day Market Update: Crude Oil Up Over 1%; Tandem Diabetes Care Shares Plunge - Benzinga
www.benzinga.com - October 14 at 8:39 AM
feeds.benzinga.com logoMid-Day Market Update: Crude Oil Up Over 1%; Tandem Diabetes Care Shares Plunge
feeds.benzinga.com - October 13 at 2:16 PM
seekingalpha.com logoTandem Diabetes Care sees ~$27M in Q3 sales; shares down 30% premarket on proposed equity offering
seekingalpha.com - October 13 at 9:22 AM
streetinsider.com logoTandem Diabetes (TNDM) Plans Offering of Common Stock, Series A Warrants and Series B Warrants
www.streetinsider.com - October 13 at 9:22 AM
rttnews.com logoTandem Diabetes Care (TNDM) Is Falling After Offering Announcement
www.rttnews.com - October 13 at 9:22 AM
finance.yahoo.com logoTandem Diabetes Care Announces Proposed Underwritten Public Offering of Common Stock, Series A Warrants and Series B Warrants
finance.yahoo.com - October 13 at 9:22 AM
finance.yahoo.com logoTandem Diabetes Care Announces Pricing of $16.2 Million Underwritten Public Offering of Common Stock and Warrants
finance.yahoo.com - October 13 at 9:22 AM
americanbankingnews.com logo$26.07 Million in Sales Expected for Tandem Diabetes Care, Inc. (TNDM) This Quarter
www.americanbankingnews.com - October 13 at 6:44 AM
americanbankingnews.com logoQ3 2017 EPS Estimates for Tandem Diabetes Care, Inc. (TNDM) Lowered by Wedbush
www.americanbankingnews.com - October 13 at 5:52 AM
seekingalpha.com logoTandem Diabetes Care readies equity offering; shares down 23% after hours
seekingalpha.com - October 12 at 4:43 PM
americanbankingnews.com logoTandem Diabetes Care, Inc. (TNDM) Expected to Post Earnings of -$3.87 Per Share
www.americanbankingnews.com - October 11 at 12:20 PM
americanbankingnews.com logoWedbush Reaffirms Outperform Rating for Tandem Diabetes Care, Inc. (TNDM)
www.americanbankingnews.com - October 10 at 9:14 AM
reuters.com logoBRIEF-Tandem Diabetes Care‍ shareholders approv reverse stock split
www.reuters.com - October 10 at 7:35 AM
reuters.com logoBRIEF-Tandem Diabetes Care‍ shareholders approv reverse stock split
www.reuters.com - October 10 at 7:35 AM
seekingalpha.com logoTandem Diabetes to reverse split shares 1:10 after the close; shares off 4% premarket
seekingalpha.com - October 10 at 7:35 AM
seekingalpha.com logoTandem Diabetes to reverse split shares 1:10 after the close; shares off 4% premarket
seekingalpha.com - October 10 at 7:35 AM
finance.yahoo.com logoTandem Diabetes Care Announces Approval of Reverse Stock Split
finance.yahoo.com - October 10 at 7:34 AM
finance.yahoo.com logoTandem Diabetes Care Announces Approval of Reverse Stock Split
finance.yahoo.com - October 10 at 7:34 AM
reuters.com logoJohnson & Johnson unit exits insulin pump business amid rising competition
www.reuters.com - October 7 at 9:14 AM
americanbankingnews.com logoTandem Diabetes Care, Inc. (TNDM) Rating Reiterated by Piper Jaffray Companies
www.americanbankingnews.com - October 6 at 9:44 PM
finance.yahoo.com logoWhat Kind Of Risk And Return Should You Expect For Tandem Diabetes Care Inc (TNDM)?
finance.yahoo.com - October 6 at 11:30 AM
americanbankingnews.com logoTandem Diabetes Care, Inc. (TNDM) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - September 30 at 8:52 AM
businesswire.com logoTandem Diabetes Care Reports Rapid Uptake and High Satisfaction Scores For t:slim X2 Insulin Pump Remote Software Update Following Launch of CGM Integration
www.businesswire.com - September 29 at 10:52 AM
americanbankingnews.com logoComparing Tandem Diabetes Care (TNDM) and Inogen (INGN)
www.americanbankingnews.com - September 23 at 2:32 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Tandem Diabetes Care, Inc.
finance.yahoo.com - September 8 at 9:20 AM
americanbankingnews.com logoTandem Diabetes Care, Inc. (TNDM) Expected to Post Quarterly Sales of $26.07 Million
www.americanbankingnews.com - September 6 at 1:28 PM
americanbankingnews.com logoTandem Diabetes Care, Inc. (TNDM) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - September 5 at 8:54 AM
finance.yahoo.com logoETFs with exposure to Tandem Diabetes Care, Inc. : September 1, 2017
finance.yahoo.com - September 1 at 9:55 AM
reuters.com logoBRIEF-Tandem Diabetes Care announces FDA approval, launch of t:slim X2 insulin pump with Dexcom G5 mobile CGM integration
www.reuters.com - August 30 at 10:17 AM
finance.yahoo.com logoTandem Diabetes Care Announces FDA Approval and Launch of t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM Integration
finance.yahoo.com - August 29 at 8:47 AM
finance.yahoo.com logoToday's Research Reports on Trending Tickers: Gilead Sciences Inc. and Tandem Diabetes Care Inc.
finance.yahoo.com - August 29 at 8:46 AM
americanbankingnews.com logoTandem Diabetes Care, Inc. (TNDM) Short Interest Update
www.americanbankingnews.com - August 28 at 1:20 AM
streetinsider.com logoTandem Diabetes (TNDM) Granted Patent for Remote Bolus Feature on Medical Infusion Pumps
www.streetinsider.com - August 25 at 1:13 AM
seekingalpha.com logoTandem Diabetes awarded new U.S. patent covering insulin pump; shares ahead 4% after hours
seekingalpha.com - August 24 at 8:11 PM
finance.yahoo.com logoTandem Diabetes Care Announces Issuance of Patent Related to Remote Bolus Feature for Medical Infusion Pumps
finance.yahoo.com - August 24 at 8:11 PM
finance.yahoo.com logoTandem Diabetes Care Announces Launch of t:lock Connector for its Insulin Pump Cartridges and Infusion Sets
finance.yahoo.com - August 23 at 12:39 PM
americanbankingnews.com logoCritical Contrast: Exactech (EXAC) and Tandem Diabetes Care (TNDM)
www.americanbankingnews.com - August 21 at 2:24 PM
americanbankingnews.com logoTandem Diabetes Care, Inc. (TNDM) Expected to Post Quarterly Sales of $26.16 Million
www.americanbankingnews.com - August 18 at 9:42 AM
americanbankingnews.com logoTandem Diabetes Care Inc (TNDM) Expected to Post Earnings of -$0.44 Per Share
www.americanbankingnews.com - August 16 at 4:32 PM
finance.yahoo.com logoTandem Diabetes Care Begins Enrollment in Pivotal Trial for First Touchscreen Insulin Pump with Predictive Low Glucose Suspend (PLGS)
finance.yahoo.com - August 16 at 8:17 AM
americanbankingnews.com logoInvacare Corporation (IVC) versus Tandem Diabetes Care (TNDM) Financial Review
www.americanbankingnews.com - August 15 at 11:10 AM
finance.yahoo.com logoETFs with exposure to Tandem Diabetes Care, Inc. : August 14, 2017
finance.yahoo.com - August 15 at 7:46 AM
americanbankingnews.com logoTandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - August 11 at 5:06 PM

Social

Chart

Tandem Diabetes Care (TNDM) Chart for Saturday, October, 21, 2017

This page was last updated on 10/21/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.